ScribbleLive

@Edano You mean it's not a new breeding population? The nukes are responsible??

(I'm still kinda stuck on the Japanese canning up all that Fukushima and Miyagi seafood to send to third world countries to prove the food is safe.)

@lillymunster Are you wondering if that 1999 study @ElaineKirk posted (which the IAEA recently uploaded) is a clue to #3 possible prompt criticality? I sure am. If I understand the paper correctly, it posits a criticality caused by the control rods melting before the fuel rods get mis-shapen, and getting sprayed with unboronated water. The water acts as facillitator to recriticality. That causes containment failure within 1.3h. after criticality. Is this possible at #3?
www.iaea.org

To emphasize: There have been no detectable health effects from exposure to radioactive cesium after the accident. www.livescience.com If this is the case why all the panic over cesium???? This appears to be the ONLY mention I could find that there are NO DOCUMENTED HEALTH CONSEQUENCES FOR CESIUM AT CHERNOBYL. Isn't this worth publicizing??

Just for the record, I was snooping around for Chernobyl radiation victims with ARS and found this report of note with the title "Bone Marrow Transplantation after the Chernobyl Nuclear Accident" published in the New England Journal many years ago: www.nejm.org . Unfortunately, you need a subscription. Below is the abstract:
On April 26, 1986, an accident at the Chernobyl nuclear power station in the Soviet Union exposed about 200 people to large doses of total-body radiation. Thirteen persons exposed to estimated total-body doses of 5.6 to 13.4 Gy received bone marrow transplants.
Two transplant recipients, who received estimated doses of radiation of 5.6 and 8.7 Gy, are alive more than three years after the accident. The others died of various causes, including burns (the cause of death in five), interstitial pneumonitis (three), graft-versus-host disease (two), and acute renal failure and adult respiratory distress syndrome (one). There was hematopoietic (granulocytic) recovery in nine transplant recipients who could be evaluated, six of whom had transient partial engraftment before the recovery of their own marrow. Graft-versus-host disease was diagnosed clinically in four persons and suspected in two others.
Although the recovery of endogenous hematopoiesis may occur after exposure to radiation doses of 5.6 to 13.4 Gy, we do not know whether it is more likely after the transient engraftment of transplanted stem cells. Because large doses of radiation affect multiple systems, bone marrow recovery does not necessarily ensure survival. Furthermore, the risk of graft-versus-host disease must be considered when the benefits of this treatment are being weighed. (N Engl J Med 1989; 321:205–12.)
We are indebted to the Soviet physicians, nurses, and military personnel who helped in the evaluation, transportation, and medical care of the patients; to Drs. Andrei Vorobiev, Leonid Ilyan, Richard O'Reilly, and many others; to Drs. John Hansen and John Goldman, who coordinated the search for unrelated donors; to Sharon Wells-Dazo, Kirsten Laage, and Bonnie Tumminia of the Occidental Petroleum Corporation, Linda Rodman and Shaun Capurro of the University of California at Los Angeles, Nina Vlasova, and Tamar Gale, who worked tirelessly to provide communication links; to Drs. Victor Voskresinskiy, Ivan Nikitin, and Nikolai Fetisov and Vice-Minister Oleg Sheppin of the Soviet Ministry of Health; to Dr. Eugeny Chazov, who allowed us access to equipment and supplies from the Soviet National Heart Institute; to Dr. Mortimer Bortin, the Advisory Committee, and the collaborating institutions of the International Bone Marrow Transplant Registry, who made their resources available; to Richard Jacobs of the Occidental Petroleum Corporation, who had a critical organizational role; to Dr. Howard Shulman, who along with Soviet pathologists, reviewed the histologic material; to Baxter Healthcare, Coulter Electronics, Sandoz Pharmaceuticals, Diagnostic Products Corporation, and Smith-Kline Beckman for generous gifts; to Drs. Drew Winston and Winston Ho, who provided assistance, antibiotics, and good advice; to President Mikhail Gorbachev for inviting the International Bone Marrow Transplant Registry to participate in the medical response to the Chernobyl accident; and to Dr. Armand Hammer, without whose generous support none of this would have been possible. Dr. Evgeny Piatkin died on December 23, 1987; we dedicate this article to him and to the brave persons who lost their lives trying to control the Chernobyl accident.

@artnuke More: 3.How have researchers learned about cancer risks from nuclear power plant accidents?

Much of what is known about cancer caused by radiation exposures from nuclear power plant accidents comes from research on the April 1986 nuclear power plant disaster at Chernobyl, in what is now Ukraine. The radioactive isotopes released during the Chernobyl accident included I-131, Cs-137, and Sr-90.

Approximately 600 workers at the power plant during the emergency received very high doses of radiation and suffered from radiation sickness. All of those who received more than 6 grays (Gy) of radiation became very sick right away and subsequently died. Those who received less than 4 Gy had a better chance of survival. (A Gy is a measure of the amount of radiation absorbed by a person’s body.)

Hundreds of thousands of people who worked as part of the cleanup crews in the years after the accident were exposed to lower external doses of ionizing radiation, ranging from approximately 0.14 Gy in 1986 to 0.04 Gy in 1989. In this group of people, there was an increased risk of leukemia.

Approximately 6.5 million residents of the contaminated areas surrounding Chernobyl received much lower amounts of radiation. From 1986 through 2005, these people received an accumulated average dose of 0.0092 Gy from external and internal sources of radiation. Children and adolescents exposed to I-131 showed an increased risk of developing thyroid cancer. (from the National Cancer Institute at the National Institutes of Health) www.cancer.gov